Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical Review

키워드

참고문헌 (100)

1. Fayyad-Kazan, M., "The potential of mesenchymal stromal cells in immunotherapy", Immunotherapy, 8, pp.839~842 (2016)
2. Hass, R., "Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC", Cell Commun. Signal, 9, pp.12~ (2011)
3. El, O. R., "Umbilical cord mesenchymal stem cells:the new gold standard for mesenchymal stem cell-based therapies?", Tissue Eng. Part B Rev, 20, pp.523~544 (2014)
4. Owen, M., "Stromal stem cells:marrow-derived osteogenic precursors", Ciba Found. Symp, 136, pp.42~60 (1988)
5. Caplan, A. I., "The MSC : an injury drugstore", Cell Stem Cell, 9, pp.11~15 (2011)
6. Horwitz, E. M., "Clarification of the nomenclature for MSC : The International Society for Cellular Therapy position statement", Cytotherapy, 7, pp.393~395 (2005)
7. Dominici, M., "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement", Cytotherapy, 8, pp.315~317 (2006)
8. Pittenger, M. F., "Multilineage potential of adult human mesenchymal stem cells", Science, 284, pp.143~147 (1999)
9. Anthony, B. A., "Regulation of hematopoietic stem cells by bone marrow stromal cells", Trends Immunol, 35, pp.32~37 (2014)
10. Fajardo-Orduna, G. R., "Hematopoietic support capacity of mesenchymal stem cells: Biology and clinical potential", Arch. Med. Res, 46, pp.589~596 (2015)
11. Frenette, P. S., "Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine", Annu. Rev. Immunol, 31, pp.285~316 (2013)
12. Battiwalla, M., "Mesenchymal stem cells in hematopoietic stem cell transplantation", Cytotherapy, 11, pp.503~515 (2009)
13. Baksh, D., "Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow", Stem Cells, 25, pp.1384~1392 (2007)
14. De Ugarte, D. A., "Comparison of multi-lineage cells from human adipose tissue and bone marrow", Cells Tissues Organs, 174, pp.101~109 (2003)
15. Kariminekoo, S., "Implications of mesenchymal stem cells in regenerative medicine", Artif. Cells Nanomed. Biotechnol, 44, pp.749~757 (2016)
16. Najar, M., "The immunomodulatory potential of mesenchymal stromal cells:A story of a regulatory network", J. Immunother, 39, pp.45~59 (2016)
17. Najar, M., "Mesenchymal stromal cells and immunomodulation : A gathering of regulatory immune cells", Cytotherapy, 18, pp.160~171 (2016)
18. Matthew B Murphy, "Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine", Experimental and Molecular Medicine, 45, pp.1~16 (2013), 생화학분자생물학회
19. Uccelli, A., "Mesenchymal stem cells: a new strategy for immunosuppression?", Trends Immunol, 28, pp.219~226 (2007)
20. Reddy, P., "Immunobiology of acute graft-versus-host disease", Blood Rev, 17, pp.187~194 (2003)
21. Hwa, C. H., "Role of toll-like receptors on human adipose-derived stromal cells", Stem Cells, 24, pp.2744~2752 (2006)
22. Pevsner-Fischer, M., "Regulatory Networks in Stem Cells. Stem Cell Biology and Regenerative Medicine", pp.175~184 (2009), Humana Press
23. Janeway, C. A. Jr., "Innate immune recognition", Annu. Rev. Immunol, 20, pp.197~216 (2002)
24. Kawai, T., "The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors", Nat. Immunol, 11, pp.373~384 (2010)
25. Medzhitov, R., "Recognition of microorganisms and activation of the immune response", Nature, 449, pp.819~826 (2007)
26. Kumar, H., "Pathogen recognition by the innate immune system", Int. Rev. Immunol, 30, pp.16~34 (2011)
27. Rich, T., "Toll and Toll-Like Receptors:: An Immunologic Perspective", pp.25~26 (2007), Springer Science & Business Media
28. kashi-Takamura, S., "TLR accessory molecules", Curr. Opin. Immunol, 20, pp.420~425 (2008)
29. Jin, M. S., "Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide", Cell, 130, pp.1071~1082 (2007)
30. Kang, J. Y., "Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer", Immunity, 31, pp.873~884 (2009)
31. Kumar, H., "Pathogen recognition in the innate immune response", Biochem. J, 420, pp.1~16 (2009)
32. Takeuchi, O., "Pattern recognition receptors and inflammation", Cell, 140, pp.805~820 (2010)
33. Guan, Y., "Human TLRs 10 and 1share common mechanisms of innate immune sensing but not signaling", J. Immunol, 184, pp.5094~5103 (2010)
34. Zanin-Zhorov, A., "Signaling via TLR2and TLR4 directly down-regulates T cell effector functions:The regulatory face of danger signals", Front. Immunol, 4, pp.211~ (2013)
35. Huang, Y., "Inflammatory bowel disease related innate immunity and adaptive immunity", Am. J. Transl. Res, 8, pp.2490~2497 (2016)
36. Ishihara, S., "Therapeutic targeting of toll-like receptors in gastrointestinal inflammation", Curr. Pharm. Des, 12, pp.4215~4228 (2006)
37. Yamamoto-Furusho, J. K., "Innate immunity in inflammatory bowel disease", World J. Gastroenterol, 13, pp.5577~5580 (2007)
38. Fuenzalida, P., "Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium-induced colitis model", Cytotherapy, 18, pp.630~641 (2016)
39. Parker, L. C., "Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity", Clin. Exp. Immunol, 147, pp.199~207 (2007)
40. Jayalakshmi Krishnan, "Toll-like receptor signal transduction", Experimental and Molecular Medicine, 39(4), pp.421~438 (2007), 생화학분자생물학회
41. Iwasaki, A., "Toll-like receptor control of the adaptive immune responses", Nat. Immunol, 5, pp.987~995 (2004)
42. Medzhitov, R., "Toll-like receptors and innate immunity", Nat. Rev. Immunol, 1, pp.135~145 (2001)
43. Vaknin, I., "A common pathway mediated through Toll-like receptors leads to T-and natural killer-cell immunosuppression", Blood, 111, pp.1437~1447 (2008)
44. Hornef, M. W., "The role of epithelial Toll-like receptor expression in host defense and microbial tolerance", J. Endotoxin Res, 11, pp.124~128 (2005)
45. Yang, X., "Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling", Am. J. Physiol. Heart Circ. Physiol, 289, pp.H1069~H1076 (2005)
46. Pevsner-Fischer, M., "Toll-like receptors and their ligands control mesenchymal stem cell functions", Blood, 109, pp.1422~1432 (2007)
47. Lombardo, E., "Toll-like receptormediated signaling in human adipose-derived stem cells:implications for immunogenicity and immunosuppressive potential", Tissue Eng. Part A, 15, pp.1579~1589 (2009)
48. Tomchuck, S. L., "Tolllike receptors on human mesenchymal stem cells drive their migration and immunomodulating responses", Stem Cells, 26, pp.99~107 (2008)
49. Opitz, C. A., "Tolllike receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2, 3-dioxygenase-1 via interferon-beta and protein kinase R", Stem Cells, 27, pp.909~919 (2009)
50. Krampera, M., "Immune regulation by mesenchymal stem cells derived from adult spleen and thymus", Stem Cells Dev, 16, pp.797~810 (2007)
51. Romieu-Mourez, R., "Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype", J. Immunol, 182, pp.7963~7973 (2009)
52. Wang, X., "Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34+ cells", Exp. Cell Res, 318, pp.196~206 (2012)
53. Raicevic, G., "Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells", Hum. Immunol, 71, pp.235~244 (2010)
54. Raicevic, G., "The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties", Cell. Immunol, 270, pp.207~216 (2011)
55. van den Berk, L. C., "Toll-like receptor triggering in cord blood mesenchymal stem cells", J. Cell. Mol. Med, 13, pp.3415~3426 (2009)
56. Sato, B. L., "Human amnion mesenchymal cells are pro-inflammatory when activated by the Toll-like receptor 2", 6 ligand, macrophage-activating lipoprotein-2, 2016, pp.44, 69~79
57. Tomic, S., "Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists", Stem Cells Dev, 20, pp.695~708 (2011)
58. Cho, H. H., "NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression", J. Cell. Physiol, 223, pp.168~177 (2010)
59. Chen, G. Y., "Baculovirus transduction of mesenchymal stem cells triggers the toll-like receptor 3 pathway", J. Virol, 83, pp.10548~10556 (2009)
60. Sung, D. K., "Antibacterial effect of mesenchymal stem cells against Escherichia coli is mediated by secretion of beta- defensin- 2 via toll- like receptor 4 signalling", Cell. Microbiol, 18, pp.424~436 (2016)
61. Fawzy-El-Sayed, K., "TlR expression profile of human gingival margin-derived stem progenitor cells", Med. Oral Patol. Oral Cir. Bucal, 21, pp.e30~e38 (2016)
62. DelaRosa, O., "Modulation of adult mesenchymal stem cells activity by toll-like receptors:implications on therapeutic potential", Mediators Inflamm, 2010, pp.865601~ (2010)
63. Kota, D. J., "Differential MSC activation leads to distinct mononuclear leukocyte binding mechanisms", Sci. Rep, 4, pp.4565~ (2014)
64. Liotta, F., "Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling", Stem Cells, 26, pp.279~289 (2008)
65. Waterman, R. S., "A new mesenchymal stem cell (MSC)paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype", PLoS One, 5, pp.e10088~ (2010)
66. Zhang, L., "The role of Toll-like receptor 3 and 4 in regulating the function of mesenchymal stem cells isolated from umbilical cord", Int. J. Mol. Med, 35, pp.1003~1010 (2015)
67. Ryu, J. H., "Tonsil-derived mesenchymal stromal cells produce CXCR2-binding chemokines and acquire follicular dendritic cell-like phenotypes under TLR3 stimulation", Cytokine, 73, pp.225~235 (2015)
68. Caplan, A. I., "Mesenchymal stem cells as trophic mediators", J. Cell. Biochem, 98, pp.1076~1084 (2006)
69. Kim, H. S., "Implication of NOD1 and NOD2 for the differentiation of multipotent mesenchymal stem cells derived from human umbilical cord blood", PLoS One, 5, pp.e15369~ (2010)
70. He, X., "TLR4 activation promotes bone marrow MSC proliferation and osteogenic differentiation via Wnt3a and Wnt5a signaling", PLoS One, 11, pp.e0149876~ (2016)
71. Qi, C., "Effects of tolllike receptors 3 and 4 in the osteogenesis of stem cells", Stem Cells Int, 2014, pp.917168~ (2014)
72. Zhang, W. Q., "Regulation of human mesenchymal stem cell differentiation by TREM-2. Hum", Immunol, 77, pp.476~482 (2016)
73. Mo, I. F., "Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors", BMC Cell Biol, 9, pp.52~ (2008)
74. Chen, X., "Characterization of mesenchymal stem cells under the stimulation of Toll-like receptor agonists", Dev. Growth Differ, 56, pp.233~244 (2014)
75. Raicevic, G., "Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin", Tissue Eng. Part A, 18, pp.1410~1418 (2012)
76. Valtieri, M., "The mesenchymal stromal cell contribution to homeostasis", J. Cell. Physiol, 217, pp.296~300 (2008)
77. Mendez-Ferrer, S., "Mesenchymal and haematopoietic stem cells form a unique bone marrow niche", Nature, 466, pp.829~834 (2010)
78. Shi, C., "Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating tolllike receptor ligands", Immunity, 34, pp.590~601 (2011)
79. Ziegler, P., "LPS-stimulated human bone marrow stroma cells support myeloid cell development and progenitor cell maintenance", Ann. Hematol, 95, pp.173~178 (2016)
80. Iwamura, C., "Sensing of the microbiota by NOD1 in mesenchymal stromal cells regulates murine hematopoiesis", Blood, 129, pp.171~176 (2017)
81. Bernardo, M. E., "Mesenchymal stromal cells : sensors and switchers of inflammation", Cell Stem Cell, 13, pp.392~402 (2013)
82. Hwang, S. H., "Toll like receptor 3 & 4 responses of human turbinate derived mesenchymal stem cells: stimulation by double stranded RNA and lipopolysaccharide", PLoS One, 9, pp.e101558~ (2014)
83. Tomchuck, S. L., "Toll-like receptor 3 and suppressor of cytokine signaling proteins regulate CXCR4 and CXCR7expression in bone marrow-derived human multipotent stromal cells", PLoS One, 7, pp.e39592~ (2012)
84. Najar, M., "Impact of different mesenchymal stromal cell types on T-cell activation, proliferation and migration", Int. Immunopharmacol, 15, pp.693~702 (2013)
85. Dumitru, C. A., "Stimulation of mesenchymal stromal cells (MSCs) via TLR3 reveals a novel mechanism of autocrine priming", FASEB J, 28, pp.3856~3866 (2014)
86. Yan, H., "Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor", Biochem. Biophys. Res. Commun, 448, pp.212~217 (2014)
87. Levin, S., "Divergent levels of LBP and TGFbeta1 in murine MSCs lead to heterogenic response to TLR and proinflammatory cytokine activation", Stem Cell Rev, 10, pp.376~388 (2014)
88. Lei, J., "Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity", Cell Immunol, 271, pp.147~156 (2011)
89. Weinstock, A., "Cultured mesenchymal stem cells stimulate an immune response by providing immune cells with Toll-like receptor 2 ligand", Stem Cell Rev, 11, pp.826~840 (2015)
90. Rashedi, I., "TLR3 or TLR4activation enhances mesenchymal stromal cell-mediated Treg induction via notch signaling", Stem Cells, 35, pp.265~275 (2017)
91. Wang, X., "Identification of TLR2 and TLR4induced microRNAs in human mesenchymal stem cells and their possible roles in regulating TLR signals", Mol. Med. Rep, 13, pp.4969~4980 (2016)
92. Zhao, X., "The toll-like receptor 3 ligand, poly(I : C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143", Stem Cells, 32, pp.521~533 (2014)
93. Sioud, M., "Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation", Scand. J. Immunol, 71, pp.267~274 (2010)
94. Gieseke, F., "Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation", Eur. J. Immunol, 43, pp.2741~2749 (2013)
95. Cho, K. A., "Poly I : C primes the suppressive function of human palatine tonsil-derived MSCs against Th17 differentiation by increasing PD-L1 expression", Immunobiology, 222, pp.394~398 (2017)
96. Y Qiu, "TLR3 preconditioning enhances the therapeutic efficacy of umbilical cord mesenchymal stem cells in TNBS-induced colitis via the TLR3-Jagged-1-Notch-1 pathway", Mucosal Immunology, 10(3), pp.727~742 (2016), Springer Nature[DOI]
97. Goriely, S., "How microorganisms tip the balance between interleukin-12 family members", Nat. Rev. Immunol, 8, pp.81~86 (2008)
98. Cassatella, M. A., "Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils", Stem Cells, 29, pp.1001~1011 (2011)
99. Giuliani, M., "TLR ligands stimulation protects MSC from NK killing", Stem Cells, 32, pp.290~300 (2014)
100. Lu, Y, "TLR4 plays a crucial role in MSC-induced inhibition of NK cell function", Biochem. Biophys. Res. Commun, 464, pp.541~547 (2015)

관련 논문AI추천